{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:43:51Z","timestamp":1760183031361,"version":"build-2065373602"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.rdc.2010.09.007","type":"journal-article","created":{"date-parts":[[2010,11,18]],"date-time":"2010-11-18T04:30:20Z","timestamp":1290054620000},"page":"665-680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Osteoporosis and Osteomalacia"],"prefix":"10.1016","volume":"36","author":[{"given":"Linda A.","family":"Russell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rdc.2010.09.007_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11914-009-0009-0","article-title":"Thyroid-stimulating hormone, thyroid hormones, and bone loss","volume":"7","author":"Zaidi","year":"2009","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"10.1016\/j.rdc.2010.09.007_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4149\/endo_2010_02_57","article-title":"Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women","volume":"44","author":"Baqi","year":"2010","journal-title":"Endocr Regul"},{"key":"10.1016\/j.rdc.2010.09.007_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1196\/annals.1402.062","article-title":"Bone loss in thyroid disease: role of low TSH and high thyroid hormone","volume":"1116","author":"Abe","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.rdc.2010.09.007_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1210\/jcem-70-1-49","article-title":"Bone Gla protein and sex hormone-binding globulin in nontoxic goiter: parameters for metabolic status at the tissue level","volume":"70","author":"Faber","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"18","key":"10.1016\/j.rdc.2010.09.007_bib5","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/archinte.1995.00430180119013","article-title":"Thyroid hormone use and bone mineral density in elderly men","volume":"155","author":"Schneider","year":"1995","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.rdc.2010.09.007_bib6","first-page":"664","article-title":"Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans","volume":"77","author":"Rosen","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.rdc.2010.09.007_bib7","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMcp032200","article-title":"Clinical practice. asymptomatic primary hyperparathyroidism","volume":"350","author":"Bilezikian","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.rdc.2010.09.007_bib8","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A\u00a010-year prospective study of primary hyperparathyroidism with or without parathyroid surgery","volume":"341","author":"Silverberg","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.rdc.2010.09.007_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ecl.2010.02.008","article-title":"Low vitamin D status: definition, prevalence, consequences, and correction","volume":"39","author":"Binkley","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1016\/j.rdc.2010.09.007_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/jc.2008-1762","article-title":"Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Khan","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.rdc.2010.09.007_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2007.03162.x","article-title":"Primary hyperparathyroidism and the skeleton","volume":"69","author":"Mosekilde","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1016\/j.rdc.2010.09.007_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/RHU.0b013e3181bb9865","article-title":"Idiopathic hypoparathyroidism mimicking diffuse idiopathic skeletal hyperostosis","volume":"15","author":"Unverdi","year":"2009","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2010.09.007_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1590\/S0004-27302010000200019","article-title":"Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement","volume":"54","author":"Rubin","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"11","key":"10.1016\/j.rdc.2010.09.007_bib14","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","article-title":"Therapy of hypoparathyroidism with intact parathyroid hormone","volume":"21","author":"Rubin","year":"2010","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.rdc.2010.09.007_bib15","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1359\/jbmr.070716","article-title":"Relative value of 25(OH)D and 1,25(OH)2D measurements","volume":"22","author":"Lips","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"issue":"18","key":"10.1016\/j.rdc.2010.09.007_bib16","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1001\/jama.293.18.2257","article-title":"Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials","volume":"293","author":"Bischoff-Ferrari","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.rdc.2010.09.007_bib17","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1210\/jc.2006-1404","article-title":"Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials","volume":"92","author":"Boonen","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.rdc.2010.09.007_bib18","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1210\/jc.2006-1391","article-title":"A\u00a0randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls","volume":"91","author":"Carpenter","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3\u20135","key":"10.1016\/j.rdc.2010.09.007_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jsbmb.2006.12.079","article-title":"New insights into the function and regulation of vitamin D target proteins","volume":"103","author":"Christakos","year":"2007","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"3\u20135","key":"10.1016\/j.rdc.2010.09.007_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jsbmb.2006.12.087","article-title":"Use of genetically modified mice to examine the skeletal anabolic activity of vitamin D","volume":"103","author":"Goltzman","year":"2007","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"1\u20135","key":"10.1016\/j.rdc.2010.09.007_bib21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jsbmb.2004.03.040","article-title":"Which circulating level of 25-hydroxyvitamin D is appropriate?","volume":"89\u201390","author":"Lips","year":"2004","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"6","key":"10.1016\/j.rdc.2010.09.007_bib22","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1359\/jbmr.081253","article-title":"Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia","volume":"24","author":"Whyte","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"issue":"13","key":"10.1016\/j.rdc.2010.09.007_bib23","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa020028","article-title":"Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter","volume":"347","author":"Prie","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.rdc.2010.09.007_bib24","first-page":"79","article-title":"Bone loss induced by dietary magnesium reduction to 10% of the nutrient requirement in rats is associated with increased release of substance P and tumor necrosis factor-alpha","volume":"134","author":"Rude","year":"2004","journal-title":"J\u00a0Nutr"},{"issue":"4","key":"10.1016\/j.rdc.2010.09.007_bib25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ecl.2005.07.009","article-title":"Pathophysiology of age-related bone loss and osteoporosis","volume":"34","author":"Khosla","year":"2005","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10","key":"10.1016\/j.rdc.2010.09.007_bib26","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm1096-1132","article-title":"Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta","volume":"2","author":"Hughes","year":"1996","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.rdc.2010.09.007_bib27","first-page":"115","article-title":"Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.rdc.2010.09.007_bib28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1172\/JCI115588","article-title":"Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation","volume":"89","author":"Chow","year":"1992","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.rdc.2010.09.007_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S8756-3282(97)00276-7","article-title":"Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture","volume":"22","author":"Qu","year":"1998","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.rdc.2010.09.007_bib30","first-page":"289","article-title":"Anabolic effect of estrogen replacement on bone in postmenopausal women with osteoporosis: histomorphometric evidence in a longitudinal study","volume":"86","author":"Khastgir","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.rdc.2010.09.007_bib31","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/endo.140.9.7131","article-title":"Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.rdc.2010.09.007_bib32","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1172\/JCI119701","article-title":"Sex steroids and bone mass in older men. positive associations with serum estrogens and negative associations with androgens","volume":"100","author":"Slemenda","year":"1997","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"10.1016\/j.rdc.2010.09.007_bib33","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1210\/jcem.86.8.7736","article-title":"Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men","volume":"86","author":"Khosla","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.rdc.2010.09.007_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/aje\/153.3.251","article-title":"Menstrual history and risk of hip fractures in postmenopausal women. the iowa women\u2019s health study","volume":"153","author":"Nicodemus","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.rdc.2010.09.007_bib35","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.2337\/dc10-0067","article-title":"Diabetes and risk of hip fracture in the Singapore Chinese Health Study","volume":"33","author":"Koh","year":"2010","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.rdc.2010.09.007_bib36","first-page":"1194","article-title":"Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus","volume":"80","author":"Bouillon","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.rdc.2010.09.007_bib37","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1463-1326.2010.01225.x","article-title":"Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes","volume":"12","author":"Aubert","year":"2010","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.rdc.2010.09.007_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MED.0b013e328325d155","article-title":"Bone metabolism in type 2 diabetes and role of thiazolidinediones","volume":"16","author":"Vestergaard","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"10.1016\/j.rdc.2010.09.007_bib39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/SLA.0b013e31819a47d2","article-title":"Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study","volume":"249","author":"Toniato","year":"2009","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.rdc.2010.09.007_bib40","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1007\/s00464-010-1000-7","article-title":"Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation","volume":"24","author":"Guerrieri","year":"2010","journal-title":"Surg Endosc"},{"issue":"5","key":"10.1016\/j.rdc.2010.09.007_bib41","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF03346473","article-title":"Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing\u2019s syndrome","volume":"32","author":"Tauchmanova","year":"2009","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.rdc.2010.09.007_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF03345523","article-title":"Prevalence of osteopenia in men with prolactinoma","volume":"28","author":"Naliato","year":"2005","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.rdc.2010.09.007_bib43","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1515\/CCLM.1999.071","article-title":"Biomarkers of bone turnover and bone mineral density in hyperprolactinemic amenorrheic women","volume":"37","author":"Shaarawy","year":"1999","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.rdc.2010.09.007_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2474-11-35","article-title":"Effects of plasma magnesium and prolactin on quantitative ultrasound measurements of heel bone among schizophrenic patients","volume":"11","author":"Renn","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"10.1016\/j.rdc.2010.09.007_bib45","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: Improving global outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.rdc.2010.09.007_bib46","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ki.1976.42","article-title":"Bone histology in incipient and advanced renal failure","volume":"9","author":"Malluche","year":"1976","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.rdc.2010.09.007_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ki.1990.187","article-title":"Renal bone disease 1990: an unmet challenge for the nephrologist","volume":"38","author":"Malluche","year":"1990","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.rdc.2010.09.007_bib48","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.ki.5002287","article-title":"Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics","volume":"74","author":"Goodman","year":"2008","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.rdc.2010.09.007_bib49","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1172\/JCI114931","article-title":"Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo","volume":"86","author":"Naveh-Many","year":"1990","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.rdc.2010.09.007_bib50","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","article-title":"Increased risk of hip fracture among patients with end-stage renal disease","volume":"58","author":"Alem","year":"2000","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.rdc.2010.09.007_bib51","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2003.12.004","article-title":"Osteoporosis work group. Osteoporosis in chronic kidney disease","volume":"43","author":"Cunningham","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.rdc.2010.09.007_bib52","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","article-title":"Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure","volume":"56","author":"Rix","year":"1999","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.rdc.2010.09.007_bib53","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5414\/CNP73088","article-title":"Relative hypoparathyroidism and hypoalbuminemia are associated with hip fracture in hemodialysis patients","volume":"73","author":"Al Helal","year":"2010","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1016\/j.rdc.2010.09.007_bib54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.rdc.2010.09.007_bib55","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/08860221003611661","article-title":"Bone mineral densitometry in patients on hemodialysis: difference between genders and what to measure","volume":"32","author":"Orlic","year":"2010","journal-title":"Ren Fail"},{"issue":"15","key":"10.1016\/j.rdc.2010.09.007_bib56","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.rdc.2010.09.007_bib57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1010007108155","article-title":"Glucocorticoid-induced osteoporosis","volume":"2","author":"Weinstein","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"issue":"10","key":"10.1016\/j.rdc.2010.09.007_bib58","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.rdc.2010.09.007_bib59","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0169-6009(91)90139-Q","article-title":"Bone loss in response to long-term glucocorticoid therapy","volume":"8","author":"LoCascio","year":"1990","journal-title":"Bone Miner"},{"issue":"8","key":"10.1016\/j.rdc.2010.09.007_bib60","first-page":"2907","article-title":"Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip","volume":"85","author":"Weinstein","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.rdc.2010.09.007_bib61","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/art.21194","article-title":"Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients","volume":"52","author":"Curtis","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.rdc.2010.09.007_bib62","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.rdc.2010.09.007_bib63","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1677\/joe.0.1590191","article-title":"Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids","volume":"159","author":"Vidal","year":"1998","journal-title":"J\u00a0Endocrinol"},{"issue":"1","key":"10.1016\/j.rdc.2010.09.007_bib64","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W","article-title":"Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial","volume":"44","author":"Adachi","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2010.09.007_bib65","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.5650040202","article-title":"Bone histomorphometry in glucocorticoid-induced osteoporosis","volume":"4","author":"Dempster","year":"1989","journal-title":"J\u00a0Bone Miner Res"},{"issue":"8","key":"10.1016\/j.rdc.2010.09.007_bib66","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1302\/0301-620X.86B8.14834","article-title":"Apoptosis\u2013a significant cause of bone cell death in osteonecrosis of the femoral head","volume":"86","author":"Calder","year":"2004","journal-title":"J\u00a0Bone Joint Surg Br"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X10000785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X10000785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:09:20Z","timestamp":1760180960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X10000785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0889857X10000785"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2010.09.007","relation":{},"ISSN":["0889-857X"],"issn-type":[{"type":"print","value":"0889-857X"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoporosis and Osteomalacia","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2010.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}